Aleafia Health has received multiple Export Permits from Health Canada, which allow the Company to begin its first international cannabis product shipment. The Company expects to ship its branded medical cannabis oils in the next month, which will be distributed by Australian Licensed Producer CannaPacific. Aleafia Health owns a 10 per cent equity stake in CannaPacific.
“The receipt of Health Canada Export Permits enables Aleafia Health to sell high-margin, value-added cannabis products across international borders for the first time,” said Aleafia Health Chairman Julian Fantino.
"The permits allow specifically for the export of our branded medical cannabis oils, including drops and sprays. As previously announced, we have already received the corresponding Permits to Import medical cannabis products from the Australian Government’s Department of Health."
“This is such a tremendous milestone for CannaPacific. Our relationship with Aleafia Health continues to accelerate our strategic vision of leadership in the Australasian medical cannabis market,” said CannaPacific CEO Joshua Dennis. “We have the facility, the proven management team, and now the product portfolio to continue executing towards our goal.”
For more information: